GlassScriptPhysician profile
David M Farag
NPI 1609976984
$8,458.54
in general payments reported to CMS, 2019-2025
33 companies · $1,727 in 2025
The $1,727 reported for 2025 was more than what 91% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,334 · 2022: $1,739 · 2023: $1,749 · 2024: $1,911 · 2025: $1,727.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,169 · Education: $217.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,168.75 |
| Education | $217.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sun Pharmaceutical Industries INC. | $971.77 | 2021-2025 | Ilumya, Winlevi, Blu-U |
| Ucb, INC. | $676.77 | 2021-2025 | Bimzelx, Cimzia |
| Incyte Corporation | $628.62 | 2021-2025 | Opzelura |
| Regeneron Healthcare Solutions, INC. | $581.27 | 2021-2025 | Dupixent, Libtayo |
| Pfizer INC. | $546.28 | 2021-2025 | |
| Abbvie INC. | $491.46 | 2021-2024 | |
| Genzyme Corporation | $444.69 | 2021-2025 | |
| Lilly USA, LLC | $414.83 | 2021-2024 | Taltz, Olumiant, Zepbound |
| Novartis Pharmaceuticals Corporation | $414.54 | 2021-2025 | |
| Amgen INC. | $388.31 | 2022-2025 | Otezla, Otezla |
| Leo Pharma INC. | $388.01 | 2021-2025 | Anzupgo, Adbry |
| E.R. Squibb & Sons, L.L.C. | $381.55 | 2023-2025 | Sotyktu |
| Arcutis Biotherapeutics, INC. | $244.09 | 2024-2025 | Zoryve |
| Dermavant Sciences, INC. | $229.48 | 2022-2024 | Vtama |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $212.15 | 2021-2025 | Jublia, Cabtreo, Arazlo |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $200.16 | 2021-2024 | Tremfya, Remicade, Simponi |
| Verrica Pharmaceuticals INC. | $197.13 | 2023-2024 | Ycanth |
| Galderma Laboratories, L.P. | $187.26 | 2021-2025 | Nemluvio, Aklief |
| Mayne Pharma Commercial LLC | $175.90 | 2022-2025 | |
| Journey Medical Corporation | $173.67 | 2022-2025 | Emrosi |
| Almirall LLC | $91.11 | 2021-2025 | Seysara, Klisyri |
| Botanix Sb INC | $83.95 | 2025 | Sofdra |
| Biofrontera INC. | $55.82 | 2021 | |
| Epi Health, LLC | $50.10 | 2021-2022 | |
| Helsinn Therapeutics (U.S.), INC. | $48.22 | 2025 | Valchlor |
| Convatec INC. | $37.52 | 2024-2025 | |
| Organon LLC | $36.97 | 2025 | Vtama |
| Organogenesis INC. | $25.90 | 2024 | |
| Kerecis Limited | $24.06 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Boehringer Ingelheim Pharmaceuticals, INC. | $15.34 | 2022 | |
| Strata Skin Sciences, INC. | $14.80 | 2025 | Xtrac |
| Vyne Pharmaceuticals INC. | $14.43 | 2021 | |
| Mission Pharmacal Company | $12.38 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Farag listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.